Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

New Tech “Add-On” Payments Sought By Hospital On Behalf Of Firms

This article was originally published in The Gray Sheet

Executive Summary

CardiacAssist hopes to obtain new technology "add-on" inpatient reimbursement for its TandemHeart percutaneous vascular assist device (PVAD), which will be used in an estimated 200 cardiogenic shock cases in 2005
Advertisement

Related Content

AdvaMed, MDMA Take Issue With CMS’ New Tech Add-On Payment Policy
AdvaMed, MDMA Take Issue With CMS’ New Tech Add-On Payment Policy
CMS New Tech Add-On Interpretation Contested By Industry Reps
CMS New Tech Add-On Interpretation Contested By Industry Reps
Proxima, Laserscope, Medtronic Qualify For Improved Outpatient Payments
Proxima, Laserscope, Medtronic Qualify For Improved Outpatient Payments
First Device Qualifies For Add-On Payment; CMS Retains Proposed Threshold
First Device Qualifies For Add-On Payment; CMS Retains Proposed Threshold
IPPS Rule Lowers FY 2005 Add-On Threshold, Denies InFuse Application
Advertisement
UsernamePublicRestriction

Register

MT019953

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel